Exchange: NSE·Updated 04:00 PM GMT+5:30

About

Jubilant Pharmova Ltd. engages in the provision of basic organic chemicals. It operates through the following segments: Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Contract Research Development and Manufacturing Organisation, Generics, and Proprietary Novel Drugs. The Radiopharma segment is involved in products for diagnosis and treatment of various diseases, including Pulmonary Embolism, Cancer, Coronary Artery Diseaseand many others. The Allergy Immunotherapy segment provides diagnostic devices for skin testing. The CDMO Sterile Injectables segment offer manufacturing services including sterile fill and finish injectables, full-service ophthalmic offer, and ampoules. The Generics segment includes development, manufacturing, distribution, sales and marketing of generics formulations. The CRDMO segment relates to drug discovery and development services. The company was founded on June 21, 1978 and is headquartered in Noida, India.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
6,386

Frequently Asked Questions

What is Market Cap of Jubilant Pharmova Ltd.?
What is the 52-week high for Jubilant Pharmova Ltd.?
What is the 52-week low for Jubilant Pharmova Ltd.?
What is Jubilant Pharmova Ltd. stock price today?
What was Jubilant Pharmova Ltd. stock price yesterday?
What is the PE ratio of Jubilant Pharmova Ltd.?
What is the Price-to-Book ratio of Jubilant Pharmova Ltd.?
What is the 50-day moving average of Jubilant Pharmova Ltd.?
How many employees does Jubilant Pharmova Ltd. have?

Advertisement|Remove ads.